Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Non-Current Assets (2022 - 2026)

Treace Medical Concepts filings provide 4 years of Other Non-Current Assets readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 200.0% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 200.0% increase, with the full-year FY2025 number at $1.2 million, up 200.0% from a year prior.
  • Other Non-Current Assets hit $1.2 million in Q4 2025 for Treace Medical Concepts, up from $614000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.2 million in Q4 2025 to a low of $134000.0 in Q1 2022.
  • Median Other Non-Current Assets over the past 4 years was $146000.0 (2022), compared with a mean of $329250.0.
  • Biggest five-year swings in Other Non-Current Assets: crashed 32.09% in 2024 and later soared 363.01% in 2025.
  • Treace Medical Concepts' Other Non-Current Assets stood at $146000.0 in 2022, then changed by 0.0% to $146000.0 in 2023, then surged by 178.77% to $407000.0 in 2024, then skyrocketed by 200.0% to $1.2 million in 2025.
  • The last three reported values for Other Non-Current Assets were $1.2 million (Q4 2025), $614000.0 (Q3 2025), and $676000.0 (Q2 2025) per Business Quant data.